Fexofenadine

Drugs

Volumn 55, Issue 2, 1998, Pages 269-276

  Markham, Anthony ^a   Wagstaff, Antona J ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; FEXOFENADINE;

ALLERGIC REACTION; ALLERGIC RHINITIS; CLINICAL TRIAL; DROWSINESS; DRUG EFFICACY; DYSMENORRHEA; DYSPEPSIA; FATIGUE; HEADACHE; HUMAN; META ANALYSIS; NAUSEA; NONHUMAN; PHARYNGITIS; QT INTERVAL; REVIEW; URTICARIA; VIRUS INFECTION;

ANIMALS; HISTAMINE ANTAGONISTS; HUMANS; RHINITIS, ALLERGIC, SEASONAL; TERFENADINE; URTICARIA;

EID: 0031952975     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199855020-00012     Document Type: Review

References (20)

1. Hoechst Marion Roussel. Fexofenadine prescribing information. Kansas City (MO), 1996
2. Paolieri F, Riccio AM, Battifora M, et al. MDL16455A and terfenadine in vitro activity on human continuous cell lines [abstract]. Allergy 1995; 50 Suppl. 26: 77
3. Davalia JL, Abdelaziz MM, Bayram H, et al. Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and mediator release from nasal epithelial cells of seasonal allergic rhinitis. Hoechst Marion Roussel, 1997. (Data on file)
4. Joetham A, Takeda K, Ishizuka T, et al. The effects of terfenadine acid metabolite (TAM) in airway inflammation and airway hyper-responsiveness (AHR) in ovalbumin (OA) sensitized mice [abstract]. Annual International Conference of the American Lung Association (ALA) and the American Thoracic Society (ATS); 1997 May 16-21: San Francisco
5. Pratt C, Mason J, Russell T, et al. Effect of fexofenadine HCL on corrected QT interval (QTc). Hoechst Marion Roussel, 1997. (Data on file)
6. Day JH, Briscoe MP, Welsh A, et al. Onset of action, efficacy and safety of a single dose of 60 mg and 120 mg fexofenadine HCl for ragweed allergy using controlled antigen exposure in an environmental exposure unit [abstract]. J Allergy Clin Immunol 1996 Jan; 97 (Pt 3): 434
7. 1-blockade effect of fexofenadine. Ann Allergy Asthma Immunol 1997 Dec; 79: 530-2
8. Balcer SL, Baker MS, Bugos CL, et al. Comparison of fexofenadine (F), terfenadine (T), loratadine (L) and placebo (P) in a double-blind crossover trial utilizing a skin test model to examine suppression of histamine-induced wheal and flare [abstract]. Hoechst Marion Roussel, 1997. (Data on file)
9. Dockhorn RJ, Hill EK, Hafner KB, et al. The duration of inhibition of skin prick test reactions after bid administration to steady-state of the non-sedating antihistamine fexofenadine HCL. Hoechst Marion Roussel, 1997. (Data on file)
10. Robbins DK, Castles MA, Pack DJ, et al. Comparison of single and multiple dose pharmacokinetics of fexofenadine (MDL 16,455) and its enantiomers [abstract no. 8152]. Pharm Res 1996 Sep; 13 (9 Suppl.): S430
11. Russell T, Arumugham T, Eller M, et al. A comparison of MDL 16,455A pharmacokinetics by gender [abstract]. Pharm Res 1995 Sep; 12 Suppl.: 389
12. Rao N, Weilert DR, Grace MGA, et al. Pharmacokinetics of terfenadine-acid-metabolite. MDL 16,455, in healthy geriatric subjects [abstract]. Pharm Res 1995 Sep; 12 Suppl.: 386
13. Lippert C, Rao N, Eller M, et al. Pharmacokinetics of fexofenadine in liver diseased patients [abstract no. 8153]. Pharm Res 1996 Sep; 13 (9 Suppl.): S431
14. Lippert C, Ling J, Brown P, et al. Mass balance and pharmacokinetics of fexofenadine HCl in healthy, male volunteers [abstract no. 8153]. Pharm Res 1996 Sep; 13 (9 Suppl.): S390
15. Bernstein D, Schoenwetter W, Nathan R, et al. Fexofenadine: a new nonsedating antihistamine is effective in the treatment of seasonal allergic rhinitis [abstract]. J Allergy Clin Immunol 1996 Jan; 97 (Pt 3): 435
16. Tinkelman D, Falliers C, Bronsky F., et al. Efficacy and safety of fexofenadine HCl in fall seasonal allergic rhinitis [abstract]. J Allergy Clin Immunol 1996 Jan; 97 (Pt 3): 435
17. Stern M, Bloom M. Fexofenadine HCl versus cetirizine as a once daily treatment of seasonal allergic rhinitis [abstract no. 0/05]. Annual Meeting of the British Society for Allergy and Clinical Immunology: 1996 Sep 4-6; Manchester
18. Stern M, Berth-Jones J, Efficacy, tolerability and optimal dose of fexofenadine in chronic idiopathic urticaria. Hoechst Marion Roussel, 1997. (Data on file)
19. Tanner LA, Reilly M, Meltzer EO. Evaluation of quality of life and health economic measures in patients treated with fexofenadine HCl for seasonal allergic rhinitis [abstract no p91]. Annual Meeting of the American College of Allergy, Asthma and Immunology: 1996 Nov 8-13; Boston, 47
20. Russell TL, Stoltz ML, Bhargava VO, et al. Acute and subchronic dose tolerance of fexofenadine HCl in healthy male subjects [abstract]. Ann Allergy Asthma Immunol 1996 Jan; 76: 96